Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbcam Share News (ABC)

Share Price Information for Abcam (ABC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,423.00
Bid: 1,423.00
Ask: 1,427.00
Change: -21.00 (-1.45%)
Spread: 4.00 (0.28%)
Open: 1,453.00
High: 1,454.00
Low: 1,418.00
Yest. Close: 1,444.00
ABC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

Wed, 4th Mar 2020 10:13

(Alliance News) - Abcam PLC on Wednesday said it has acquired Marker Gene Technologies Inc for an undisclosed sum, with a large chunk of the US deal funded from a share issue.

Headquartered in Oregon, Marker Gene Technologies supplies reagents and assay kits to researchers in the biotechnology and medical industries.

Abcam did not disclose financial terms of the deal, but did say that "a substantial portion of the consideration for the acquisition" would come from the issue of new Abcam shares.

Abcam has applied to AIM to admit 49,416 new shares, expected to take place around Monday next week. Following this, its share capital will consist of 206.1 million shares. Shares in Abcam were up 0.2% at 1,234.00 pence in London on Wednesday morning. That makes 49,416 shares worth GBP609,793.

Abcam has a market capitalisation of GBP2.54 billion.

The deal, Abcam said, is likely to have only "a minimal impact on revenue and earnings in the current financial year".

"Following the recent acquisition of Expedeon's proteomics and immunology business, and aligned with our broader antibody-conjugation strategy, the acquisition of [Marker Gene Technologies] brings additional proprietary assay development technologies and labelling capabilities to Abcam. MGT's team have expertise in the areas of biology, organic synthesis and fluorescence chemistry and are experienced in the creation of detection tools that enable enhanced understanding of biological processes," Abcam said.

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

11 May 20 13:07

Monday broker round-up

(Sharecast News) - Abcam: RBC Capital Markets upgrades to outperform with a target price of 1,300p.

20 Apr 20 13:41

Abcam Expects Annual Revenue To Be Significantly Lower Than Planned

Abcam Expects Annual Revenue To Be Significantly Lower Than Planned

20 Apr 20 10:02

Abcam warns on revenues as Covid-19 hits markets

(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.

20 Apr 20 10:02

UK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica

UK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica

20 Apr 20 09:41

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

14 Apr 20 16:04

Abacam To Raise GBP110 Million Through Share Issue To Fund Growth

Abacam To Raise GBP110 Million Through Share Issue To Fund Growth

9 Apr 20 18:07

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

20 Mar 20 09:49

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

12 Mar 20 16:05

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

10 Mar 20 09:38

Abcam 'uncertain' about coronavirus impact as China returns to work

(Sharecast News) - Life science research tools company Abcam reported a 10.8% increase in total revenue increased 10.8% on a reported basis and 8.3% on a constant exchange rate basis in its interim results on Monday, to ?138.2m.

9 Mar 20 15:48

UK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses

UK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses

9 Mar 20 10:29

ABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue

ABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue

9 Mar 20 09:55

Abcam acquires Marker Gene Technologies

(Sharecast News) - Life sciences group Abcam extended its assay and labelling capabilities on Wednesday with the acquisition of Marker Gene Technologies for an undisclosed sum.

4 Mar 20 10:26

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

4 Mar 20 10:13

Login to your account

Don't have an account? Click here to register.